This study also found ACE2, the receptor used by SARS-CoV-2 for cellular entry, was positively correlated with IRF7 expression in both AD and COVID-19 patients, particularly in neurons and endothelial cells, as demonstrated by snRNA-seq. This evidence concerns the gene IRF7 and Alzheimer disease.